See more : GoldHaven Resources Corp. (GOH.CN) Income Statement Analysis – Financial Results
Complete financial analysis of PT Murni Sadar Tbk (MTMH.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Murni Sadar Tbk, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Ju Teng International Holdings Limited (3336.HK) Income Statement Analysis – Financial Results
- Healthcare AI Acquisition Corp. (HAIAW) Income Statement Analysis – Financial Results
- American International Holdings Corp. (AMIH) Income Statement Analysis – Financial Results
- Armour Energy Limited (AJQ.AX) Income Statement Analysis – Financial Results
- Unibail-Rodamco-Westfield SE (URW.PA) Income Statement Analysis – Financial Results
PT Murni Sadar Tbk (MTMH.JK)
About PT Murni Sadar Tbk
PT Murni Sadar Tbk, together with its subsidiaries, provides human healthcare services. It operates the Murni Teguh Memorial Hospital located in Medan; the Murni Teguh Tuban Bali Hospital located in Bali; the Murni Teguh Sudirman Jakarta Hospital located in Jakarta; the General hospital Medikarya Aminah Utama located in Tangerang; and the Rumah Sakit Ibu dan Anak Rosiva located in Medan with a total bed capacity of 858 units. The company is headquartered in Medan, Indonesia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 921.91B | 822.29B | 983.16B | 568.78B | 443.65B | 340.72B |
| Cost of Revenue | 697.30B | 604.38B | 557.70B | 400.86B | 355.57B | 263.18B |
| Gross Profit | 224.61B | 217.91B | 425.46B | 167.91B | 88.08B | 77.54B |
| Gross Profit Ratio | 24.36% | 26.50% | 43.28% | 29.52% | 19.85% | 22.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 22.70B | 2.45B | 5.04B | 1.36B | 2.69B | 3.46B |
| Selling & Marketing | 2.77B | 1.28B | 517.38M | 608.29M | 2.19B | 1.54B |
| SG&A | 25.47B | 3.73B | 5.56B | 1.97B | 4.87B | 5.00B |
| Other Expenses | 199.14B | 145.63B | 123.42B | 112.85B | 108.08B | -542.85M |
| Operating Expenses | 224.61B | 149.36B | 128.98B | 114.82B | 112.95B | 65.60B |
| Cost & Expenses | 906.71B | 753.73B | 686.67B | 515.68B | 468.52B | 328.78B |
| Interest Income | 81.23M | 1.12B | 15.53M | 8.92M | 12.17M | 32.21M |
| Interest Expense | 37.25B | 32.61B | 39.30B | 41.67B | 44.83B | 24.20B |
| Depreciation & Amortization | 57.01B | 112.95B | 72.13B | 58.51B | 19.41B | 12.37B |
| EBITDA | 80.11B | 227.09B | 300.94B | 114.30B | -16.53B | 22.99B |
| EBITDA Ratio | 8.69% | 19.51% | 33.69% | 13.46% | -3.73% | 6.75% |
| Operating Income | 15.21B | 112.52B | 301.63B | 55.16B | -35.94B | 11.94B |
| Operating Income Ratio | 1.65% | 13.68% | 30.68% | 9.70% | -8.10% | 3.51% |
| Total Other Income/Expenses | -26.69B | -32.62B | -109.38B | -39.62B | -68.84B | -25.52B |
| Income Before Tax | -11.49B | 79.89B | 187.11B | 13.47B | -93.71B | -13.57B |
| Income Before Tax Ratio | -1.25% | 9.72% | 19.03% | 2.37% | -21.12% | -3.98% |
| Income Tax Expense | 2.59B | 14.47B | 56.57B | 10.97B | -8.11B | -2.16B |
| Net Income | -12.83B | 65.96B | 130.36B | 2.50B | -85.60B | -8.44B |
| Net Income Ratio | -1.39% | 8.02% | 13.26% | 0.44% | -19.30% | -2.48% |
| EPS | -6.20 | 31.89 | 63.02 | 1.21 | -41.38 | -4.08 |
| EPS Diluted | -6.20 | 31.89 | 63.02 | 1.21 | -41.38 | -4.08 |
| Weighted Avg Shares Out | 2.07B | 2.07B | 2.07B | 2.07B | 2.07B | 2.07B |
| Weighted Avg Shares Out (Dil) | 2.07B | 2.07B | 2.07B | 2.07B | 2.07B | 2.07B |
Source: https://incomestatements.info
Category: Stock Reports